Skip to main content
logo
Encision Inc. (ECIA)
OTCMKTS · Delayed Price · Currency is USD
0.3470
-0.0189 (-5.45%)
Aug 1, 2025, 12:12 PM EDT

Ligand Pharmaceuticals Revenue

In the fiscal year ending March 31, 2025, Encision had annual revenue of $6.56M, down -0.46%. Encision had revenue of $1.58M in the quarter ending March 31, 2025, with 3.86% growth.

Revenue
6.56M
Revenue Growth
-0.46%
P/S Ratio
0.63
Revenue / Employee
285.01K
Employees
24
Market Cap
4.12M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20256.56M-30.57K-0.46%
Mar 31, 20246.59M-762.63K-10.38%
Mar 31, 20237.35M-320.12K-4.17%
Mar 31, 20227.67M130.80K1.74%
Mar 31, 20217.54M-132.37K-1.73%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Endo, Inc.1.73B
Veradigm588.02M
Tian'an Technology Group1.78M
Elite Pharmaceuticals84.04M
Glass House Brands215.62M
Northwest Biotherapeutics1.47M
American Oncology Network1.76B
Silence Therapeutics27.70M
Revenue Rankings

Encision News

More News